Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial.
about
Role of multiparametric magnetic resonance imaging in early detection of prostate cancerThe role of MRI in prostate cancer diagnosis and management.Pre-biopsy MRI as an adjunct for cancer detection in men with elevated PSA and no previous biopsy.Cost consideration in utilization of multiparametric magnetic resonance imaging in prostate cancer.Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies.Knowledge, attitudes, and practices towards prostate cancer screening amongst men living in the southern Italian peninsula: the Prevention and Research in Oncology (PRO) non-profit Foundation experience.Opportunities for multiparametric MRI with PI-RADS v2 to make a difference.Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image-fusion guided transperineal prostate biopsy in patients with a previous negative biopsy.First report of robot-assisted transperineal fusion versus off-target biopsy in patients undergoing repeat prostate biopsy.The Contemporary Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Prostate Cancer.Pre-biopsy 3-Tesla MRI and targeted biopsy of the index prostate cancer: correlation with robot-assisted radical prostatectomy.Prebiopsy multiparametric MRI-based risk score for predicting prostate cancer in biopsy-naive men with prostate-specific antigen between 4-10 ng/mL.Comparison of prostate MRI-3D transrectal ultrasound fusion biopsy for first-time and repeat biopsy patients with previous atypical small acinar proliferationThe predictive efficacy of hypoechoic lesion in ultrasound for prostate cancer in Chinese people: five-year experience in a moderated 10-core transperineal prostate biopsy procedure.Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer.Results of a comparative analysis of magnetic resonance imaging-targeted versus three-dimensional transrectal ultrasound prostate biopsies: Size does matter.Targeted versus systematic robot-assisted transperineal MRI-TRUS fusion prostate biopsy.Magnetic resonance imaging in the early detection of prostate cancer and review of the literature on magnetic resonance imaging-stratified clinical pathways.Transrectal ultrasound-guided prostate biopsies vs. magnetic resonance imaging ultrasound fusion targeted biopsies: Who are the best candidates?The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer.Prostate cancer screening-when to start and how to screen?Poor reproducibility of PIRADS score in two multiparametric MRIs before biopsy in men with elevated PSA.Cancer detection rate of prebiopsy MRI with subsequent systematic and targeted biopsy are superior to non-targeting systematic biopsy without MRI in biopsy naïve patients: a retrospective cohort study.The Use of Magnetic Resonance Imaging in the Prostate Cancer Primary Diagnostic Pathway: Is It Ready for Primetime?Photoacoustic tomography of intact human prostates and vascular texture analysis identify prostate cancer biopsy targets
P2860
Q26768765-3F567053-88DB-444C-91BE-10BAC2DE6B3AQ30245245-E569D0BF-F472-4000-B616-235250FED1B2Q33890175-5C2A8E81-E88E-4048-B814-4CDA3C406692Q33890201-80A188F7-05BC-4826-AB56-361B8855C86FQ36649765-FA45DF0B-6D7F-4244-9458-B98B80A57EFAQ38638510-D1E828A7-5C94-4FA0-AE8E-AEE38F4EFAB6Q38820008-BEF1AA13-5543-4575-A142-30DBEC7E34CDQ39174624-43F9EDE4-3A83-4DF5-A1F7-E9188F96E505Q39185003-6C255E82-2053-4906-A3FD-325D477B27A3Q39356191-8098CF90-AC82-4719-90DA-684A93C0E9E5Q39787686-FBC39AC1-E410-41DF-8F94-FB28063E860DQ40057890-D9308774-7003-4C63-BB38-814C07EF1228Q41614966-1A0A8795-526B-4455-845F-006AA61B4183Q46000995-E5C8D5C4-2467-40A5-87F0-68F4AB53EAF8Q47303003-8F78D99E-24C2-41DE-9E93-BE79DF67DC12Q47333832-C2D7E7E1-3BBA-419C-8B39-9FFDE3F9EDC7Q47357407-A2E18975-B018-46C1-9446-3401BE88EE5BQ47949163-D19366EB-52DA-4356-84BB-EAA1B837A66EQ48518147-476EFCBE-FB81-4C76-83DD-CCD4F3AD6E34Q50088856-7B7DF9B6-8C68-444C-B3CE-7266BAD9B0C9Q52624230-F749D0B2-3001-4669-8F7F-C2B6FFF6AC6CQ52672783-AE001B7E-C544-4B05-A9D3-4C499ED96ED5Q54974754-E2ADD9BF-0092-4547-AFD4-D2BB5CBAD0AFQ57107312-BE39E5B3-A181-4252-9915-02C8C8CB0E6BQ58801432-A67EBEEA-D4B8-41EE-84B5-03EF54DA46CD
P2860
Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prebiopsy Multiparametric Magn ...... tive Blinded Controlled Trial.
@en
type
label
Prebiopsy Multiparametric Magn ...... tive Blinded Controlled Trial.
@en
prefLabel
Prebiopsy Multiparametric Magn ...... tive Blinded Controlled Trial.
@en
P2093
P1433
P1476
Prebiopsy Multiparametric Magn ...... ctive Blinded Controlled Trial
@en
P2093
Eija Pääkkö
Eveliina Lammentausta
Juha Lantto
Panu P Tonttila
Pasi Ohtonen
Saila Kauppila
Ulla Piippo
P304
P356
10.1016/J.EURURO.2015.05.024
P407
P577
2015-05-29T00:00:00Z